Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000666793 | SCV000791149 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2017-05-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001855467 | SCV002228649 | pathogenic | Qualitative or quantitative defects of dysferlin | 2022-03-14 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 551669). This premature translational stop signal has been observed in individual(s) with clinical features of limb-girdle muscular dystrophy and/or dysferlinopathy (PMID: 17994539, 27647186). This sequence change creates a premature translational stop signal (p.Phe419Leufs*41) in the DYSF gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYSF are known to be pathogenic (PMID: 17698709, 20301480). This variant is present in population databases (rs766936914, gnomAD 0.0009%). This variant is also known as Pro418ProfsX123. |
Baylor Genetics | RCV003465454 | SCV004192269 | pathogenic | Miyoshi muscular dystrophy 1 | 2023-01-10 | criteria provided, single submitter | clinical testing |